Cogent Biosciences (COGT)
(Real Time Quote from BATS)
$7.88 USD
-0.15 (-1.87%)
Updated May 23, 2024 10:11 AM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (84 out of 249)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.45 | 1.35 | 9.99 |
Current Quarter Estimate | -0.55 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.59 | 0.12 | 52.54 |
Next Quarter Estimate | -0.54 | 7.81 | 61.00 |
Next Year Estimate | -2.04 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 9.50 | 15.40 | 15.67 |
Next Year | 6.85 | 8.30 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 3.84 | 2.31 |
Price/Cash Flow (MRFY) | NA | 17.10 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -153.43% |
Return on Equity (TTM) | -91.56% | -58.74% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.